# LAG3 PET Imaging in Advanced Solid Tumors

> **NCT04706715** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 41 (actual)

## Conditions studied

- Metastatic Solid Tumor

## Interventions

- **OTHER:** 89Zr-DFO-REGN3767
- **DRUG:** Cemiplimab

## Key facts

- **NCT ID:** NCT04706715
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-18
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04706715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04706715, "LAG3 PET Imaging in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04706715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*